Trials / Sponsors / Orasis Pharmaceuticals Ltd.
Orasis Pharmaceuticals Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | An Evaluation of the Safety of CSF-1 in Presbyopic Subjects Presbyopia | Phase 3 | 2022-04-22 |
| Completed | An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2) Presbyopia | Phase 3 | 2020-10-26 |
| Completed | An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) Presbyopia | Phase 3 | 2020-10-18 |
| Completed | A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia Presbyopia | Phase 2 | 2019-02-26 |
| Completed | Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects Presbyopia | Phase 2 | 2016-12-01 |
| Completed | Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia Presbyopia | Phase 2 | 2016-07-01 |